Press release - 25/09/2023 Autonomous outdoor navigation for machines used in farming, livestock and forestry Autonomous and robust navigation is an essential capability for agricultural robots or machines that are to reach a new level of autonomy to manoeuver safely and reliably in their environment. Fraunhofer IPA will showcase what is currently technologically and economically feasible with live demos at agritechnica, the agricultural trade fair taking place in Hanover from November 12 to 18, 2023.https://www.biooekonomie-bw.de/en/articles/pm/autonomous-outdoor-navigation-machines-used-farming-livestock-and-forestry
Press release - 21/09/2023 Mutation-specific peptide vaccine against midline gliomas used in patients for the first time Tumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are harbouring cancer-typical alterations. Physicians and cancer researchers from Heidelberg and Mannheim have now treated adult patients with advanced midline gliomas, difficult-to-treat brain tumors, with a peptide vaccine for the first time.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mutation-specific-peptide-vaccine-against-midline-gliomas-used-patients-first-time
Press release - 19/09/2023 Better distinguish chronic inflammation and cancer of the pancreas Current diagnostic methods do not always reliably distinguish between chronic inflammation of the pancreas and pancreatic cancer. About one third of all diagnoses are inconclusive. Scientists from the German Cancer Research (DKFZ) and from Heidelberg University Hospital (UKHD) therefore searched for molecular markers that could specify this diagnosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/chronische-entzuendung-und-krebs-der-bauchspeicheldruese-praeziser-unterscheiden
Press release - 14/09/2023 The Cultivated B Initiated Pre-Submission Process towards EFSA Certification for Cultivated Sausage The Cultivated B (TCB) began discussions with the European Food Safety Authority (EFSA) and officially entered the pre-submission process for novel food approval of a novel or non-farmed sausage product. Subsequent to the official submission, TCB will emerge as world’s first biotech company to apply for EFSA certification for cultivated meat. This is a pivotal first step in the evolution of the cultivated meat market.https://www.biooekonomie-bw.de/en/articles/pm/cultivated-b-initiated-pre-submission-process-towards-efsa-certification-cultivated-sausage
Event - 04/12/2023 - 05/12/2023 Bioeconomy Forum 2023 Berlin, Kongress/Symposium https://www.biooekonomie-bw.de/en/events/bioeconomy-forum-2023
Project SMARTGAIT - 13/09/2023 Safe and cost-effective analysis of neurological gait disorders with AI Stroke, Parkinson's disease and multiple sclerosis often resulting in gait disorders in those affected. Gait analyses play a crucial role in the successful evaluation and therapy of such disorders. Current measurement methods are costly and time-consuming. The SMARTGAIT project is therefore developing an innovative AI-based system aimed at performing meaningful gait analyses with the help of simple smartphone video recordings.https://www.gesundheitsindustrie-bw.de/en/article/news/safe-and-cost-effective-analysis-neurological-gait-disorders-ai
Food of the future: new production methods - 06/09/2023 NewFoodSystems: innovation space for tomorrow’s food A rapidly growing world population and simultaneously rapidly shrinking arable land – these are just some of the major challenges facing the food industry. But how can solutions be found? Answers are being sought by the bioeconomy innovation space NewFoodSystems. Funded by the German Federal Ministry of Education and Research (BMBF), it is a network where science and industry can come together to develop sustainable food systems of the future.https://www.biooekonomie-bw.de/en/articles/news/newfoodsystems-innovation-space-tomorrows-food
Sustainability report - 31/08/2023 ReKlimaMed: how effective is the German healthcare sector when it comes to sustainability? Hospitals, care facilities and the healthcare industry, together with laboratories, private practices and pharmacies, ensure our medical care, but in so doing they produce enormous amounts of greenhouse gases and consume many resources. The ReKlimaMed report prepared by the viamedica foundation presents an inventory of current sustainable activities, and provides stakeholders with information and recommendations for action.https://www.gesundheitsindustrie-bw.de/en/article/news/reklimamed-how-effective-german-healthcare-sector-when-it-comes-sustainability
Press release - 30/08/2023 Soil Salinity: Wild Grapevine Defends Itself Rising sea levels due to climate change and artificial irrigation cause soil salinity to increase. This has a negative impact on agriculture, including viticulture. The plants die, yields decrease. Researchers of Karlsruhe Institute of Technology (KIT) have therefore studied a wild grapevine of higher salt tolerance. Their goal is to identify the genetic factors that make the grapevine resilient.https://www.biooekonomie-bw.de/en/articles/pm/soil-salinity-wild-grapevine-defends-itself
Press release - 28/08/2023 Innovative computational approach helps design proteins for cancer treatment The computational design of new proteins for biomedical or other applications involves long computing times on powerful servers. A joint team of researchers from the Max Planck Institute for Biology Tübingen and the University Hospital Tübingen has now developed and tested a new computational method to greatly speed up the necessary energy calculations. Their framework allows for a precise and efficient design of functional proteins.https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-computational-approach-helps-design-proteins-cancer-treatment
DNA nanotechnology - 25/08/2023 Artificial cytoskeleton made of DNA for synthetic cells The physicists Prof. Dr. Kerstin Göpfrich and Prof. Dr. Laura Na Liu want to understand life from the bottom up. They intend to do this by constructing an artificial cell. However, rather than natural protein building blocks, they are using 3D-DNA structures as construction material. The first step involved creating an artificial cell skeleton that dynamically assembles and disassembles like the biological model and can transport vesicles.https://www.gesundheitsindustrie-bw.de/en/article/news/artificial-cytoskeleton-made-dna-synthetic-cells
Press release - 18/08/2023 TÜV SÜD gets UK Approved Body designation TÜV SÜD has received approval as a UK Approved Body (UKAB) for medical devices. With this approval, medical device manufacturers can implement UKCA certification for the UK market and CE certification for the European market in a time- and cost-efficient manner with TÜV SÜD.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tuev-sued-gets-uk-approved-body-designation
Event - 15/11/2023 Networking Evening | Baden-Württemberg meets United Kingdom 2023 Medica trade fair, Baden-Württemberg joint booth K16, Hall 15, Messe https://www.bio-pro.de/en/events/past-events/networking-evening-baden-wuerttemberg-meets-united-kingdom-2023
Press release - 10/08/2023 Computer-aided cell analysis for faster diagnosis of blood diseases Scientists from the German Cancer Research Center (DKFZ) and the Cambridge Stem Cell Institute have developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples. The algorithm can help physicians diagnose blood disorders and is available as an open source method for research purposes.https://www.gesundheitsindustrie-bw.de/en/article/press-release/computergestuetzte-zellanalyse-fuer-die-schnellere-diagnose-von-blutkrankheiten
Press release - 07/08/2023 Vegan trend in Europe: In Germany, milk substitutes from plants are most popular alternative Germany has the most active market, Southern Europe wants more variety, and people in Poland find dairy substitutes too expensive, according to a recent study by the University of Hohenheim.https://www.gesundheitsindustrie-bw.de/en/article/press-release/vegan-trend-europe-germany-milk-substitutes-plants-are-most-popular-alternative
Press release - 07/08/2023 Vegan trend in Europe: In Germany, milk substitutes from plants are most popular alternative Germany has the most active market, Southern Europe wants more variety, and people in Poland find dairy substitutes too expensive, according to a recent study by the University of Hohenheim.https://www.biooekonomie-bw.de/en/articles/pm/vegan-trend-europe-germany-milk-substitutes-plants-are-most-popular-alternative
Overview Press release was not found https://www.bio-pro.de/en/information/press-release/press-release-was-not-found
Overview Press release was not found https://www.gesundheitsindustrie-bw.de/en/article/press-release/press-release-was-not-found
Overview Dossier was not found https://www.gesundheitsindustrie-bw.de/en/article/dossier/dossier-was-not-found
Overview Article was not found https://www.gesundheitsindustrie-bw.de/en/article/news/article-was-not-found
Overview Dossier was not found https://www.biooekonomie-bw.de/en/articles/dossiers/dossier-was-not-found
Overview Press release was not found https://www.biooekonomie-bw.de/en/articles/pm/press-release-was-not-found
Project BlindZero - 03/08/2023 Hope for patients with eye diseases: human cornea from 3D printers Thousands of cornea transplants are performed every year. However, donors are rare and the procedure is not always without complications. Researchers at the University of Heidelberg are developing an innovative technique in the project BlindZero. It involves ‘printing’ human corneas directly onto patients’ eyes using 3D bioprinting. The reprogrammed genetically engineered cells used for this purpose are not expected to cause a rejection reaction.https://www.gesundheitsindustrie-bw.de/en/article/news/hope-patients-eye-diseases-human-cornea-3d-printers
Press release - 02/08/2023 Freiburg research team casts light on signal-dependent formation of mitochondria Known as the power plant of the cell, mitochondria are essential to human metabolism. Human mitochondria consist of 1,300 different proteins and two fatty biomembranes. The vast majority of mitochondrial proteins are produced with a cleavable transport signal and have to be actively transported into the mitochondria. https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburger-forschungsteam-klaert-signalabhaengige-bildung-von-mitochondrien-auf